SZE-LING NG is currently a scientific leader at GlaxoSmithKline, working in Immunology drug discovery and development.
She trained as a post-doctoral research fellow in the Department of Stem Cell and Regenerative Biology at Harvard University, studying regulatory T cells in the autoimmune disease multiple sclerosis.
Sze-Ling received her Ph.D. from the Department of Molecular and Cellular Biology at Harvard University. As a graduate student, she studied the role of IKKe in JAK/STAT signaling during the antiviral immune response. Sze-Ling received two BS degrees in Biochemistry and Physiology from Michigan State University, and graduated with a perfect 4.0 GPA from the Honors College.
Sze-Ling has published in multiple high impact journals such as PNAS, Science, and Molecular Cell. She is the recipient of a National Multiple Sclerosis Society Post-doctoral Fellowship, National Science Foundation Graduate Research Fellowship, Bok Center Certificate of Distinction in Teaching, Featherstone Prize, and Michigan State University Board of Trustees Award.
Sze-Ling aspires to conduct research that will benefit society, and to encourage youth to pursue a higher education and science-related careers. She has taught various students, led several organizations, and performed service work.
